birth defects from semaglutide GLP1-RAs: The New Era of Diabetes and Weight Loss Management, FAQs in Pregnancy and Lactation Millions are racing to get

These findings point to a central mechanismbeyond weight loss and blood sugar controlwhere GLP1 medicines are acting directly on the brain to support cognition, mood, and neural health

In recent years, GLP-1 drugs have been brought to market to make this management much easier for patients with diabetes

The result is lighter sleep, more frequent awakenings, and a feeling of not being rested even after spending adequate time in bed

2020, Jan, 8;17(1):11

This mechanism contributes to weight loss, with clinical trials of semaglutide 2.4mg (Wegovy) demonstrating average weight reductions of 1015% of body weight over 1218 months

The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres